# Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™

> **NCT03462563** · PHASE3 · TERMINATED · sponsor: **Ethicon, Inc.** · enrollment: 175 (actual)

## Conditions studied

- Subjects Scheduled to Undergo Laparoscopic Radical Resection of Rectal Carcinoma With Preventive Ileostomy

## Interventions

- **DEVICE:** INTERCEED™
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT03462563
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-16
- **Primary completion:** 2021-02-24
- **Final completion:** 2021-02-24
- **Target enrollment:** 175 (ACTUAL)
- **Why stopped:** The study was terminated because the pre-specified study stopping criterion has been met.
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03462563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03462563, "Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03462563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*